130 related articles for article (PubMed ID: 18094558)
1. [Laboratory evaluation of bone marrow metastasis: single institute study].
Yun HK; Shin MG; Bo D; Kim DW; Cho D; Shin JH; Suh SP; Ryang DW
Korean J Lab Med; 2007 Apr; 27(2):96-101. PubMed ID: 18094558
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and cytomorphological features of bone marrow metastasis of non-hematological malignant carcinoma].
Li L; Cong Y; Cai L; Deng X; Guan J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Oct; 34(10):1541-5. PubMed ID: 25345959
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow involvement by metastatic solid tumors.
Sharma S; Murari M
Indian J Pathol Microbiol; 2003 Jul; 46(3):382-4. PubMed ID: 15025279
[TBL] [Abstract][Full Text] [Related]
4. Presence of differentiating neuroblasts in bone marrow is a favorable prognostic factor for bone marrow metastatic neuroblastoma at diagnosis.
Park SH; Kim S; Park CJ; Jang S; Chi HS; Koh KN; Im HJ; Seo JJ
Ann Lab Med; 2013 Mar; 33(2):89-96. PubMed ID: 23483759
[TBL] [Abstract][Full Text] [Related]
5. Combined use of multiparametric flow cytometry and cytomorphology to enhance detection of neuroblastoma metastatic cells in bone marrow.
Manenq C; Lesesve JF; Dreumont N; Massin F; Salignac S; Mansuy L; Chastagner P; Latger-Cannard V; Broséus J
Int J Lab Hematol; 2020 Feb; 42(1):52-60. PubMed ID: 31821742
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel biomarkers in neuroblastoma associated with the risk for bone marrow metastasis: a pilot study.
Osman J; Galli S; Hanafy M; Tang X; Ahmed A
Clin Transl Oncol; 2013 Nov; 15(11):953-8. PubMed ID: 23553333
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow metastasis in nasopharyngeal cancer: early detection using EBER1 in situ hybridization.
Chen TY; Tsai ST; Jin YT; Su WC; Tsao CJ
Anticancer Res; 1999; 19(1B):885-8. PubMed ID: 10216511
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signature.
Scaruffi P; Morandi F; Gallo F; Stigliani S; Parodi S; Moretti S; Bonassi S; Fardin P; Garaventa A; Zanazzo G; Pistoia V; Tonini GP; Corrias MV
Pediatr Blood Cancer; 2012 Jul; 59(1):44-51. PubMed ID: 21994039
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Persistent Tumor in Bone Marrow during Treatment of High-risk Neuroblastoma.
Choi YB; Bae GE; Lee NH; Kim JS; Lee SH; Yoo KH; Sung KW; Koo HH
J Korean Med Sci; 2015 Aug; 30(8):1062-7. PubMed ID: 26240483
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow metastasis in solid tumors.
Mohanty SK; Dash S
Indian J Pathol Microbiol; 2003 Oct; 46(4):613-6. PubMed ID: 15025356
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Hematological Aspects between Neuroblastoma Patients with and without Bone Marrow Infiltration.
Wang W; Peng X; Liang C; Chen H; Zhang Y; Sun X; Shen L; Lu Y
Ann Clin Lab Sci; 2017 Aug; 47(4):416-421. PubMed ID: 28801367
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow metastases: a survey of nonhematologic metastases with immunohistochemical study of metastatic carcinomas.
Krishnan C; George TI; Arber DA
Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):1-7. PubMed ID: 17536301
[TBL] [Abstract][Full Text] [Related]
13. Platelet size has diagnostic predictive value for bone marrow metastasis in patients with solid tumors.
Aksoy S; Kilickap S; Hayran M; Harputluoglu H; Koca E; Dede DS; Erman M; Turker A
Int J Lab Hematol; 2008 Jun; 30(3):214-9. PubMed ID: 18479300
[TBL] [Abstract][Full Text] [Related]
14. ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma.
Berois N; Blanc E; Ripoche H; Mergui X; Trajtenberg F; Cantais S; Barrois M; Dessen P; Kågedal B; Bénard J; Osinaga E; Raguénez G
Clin Chem; 2006 Sep; 52(9):1701-12. PubMed ID: 16873292
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two methods for evaluating bone marrow metastasis of neuroblastoma: Reverse transcription-polymerase chain reaction for tyrosine hydroxylase and magnetic resonance imaging.
Takemoto C; Nishiuchi R; Endo C; Oda M; Seino Y
Pediatr Int; 2004 Aug; 46(4):387-93. PubMed ID: 15310300
[TBL] [Abstract][Full Text] [Related]
16. Frequency of bone marrow involvement in non-haematological malignancies.
Kumar L; Majhi U; Shanta V
J Assoc Physicians India; 1990 Aug; 38(8):553-5. PubMed ID: 2246193
[TBL] [Abstract][Full Text] [Related]
17. Measurement of tyrosine hydroxylase transcripts in bone marrow using biopsied tissue instead of aspirates for neuroblastoma.
Lee ST; Suh YL; Ko YH; Ki CS; Sung KW; Kim HJ; Kim JW; Kim SH; Chueh H; Lee SH; Yoo KH; Koo HH
Pediatr Blood Cancer; 2010 Aug; 55(2):273-8. PubMed ID: 20582938
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of the determination of bone marrow lesion in patients with neuroblastoma based on the gene PHOX2B and TH expression].
Druĭ AE; Shorikov EV; Tsaur GA; Popov AM; Tuponogov SN; Savel'ëv LI; Tsvirenko SV; Fechina LG
Vopr Onkol; 2014; 60(2):57-62. PubMed ID: 24919263
[TBL] [Abstract][Full Text] [Related]
19. Hematolymphoid neoplasms are common in bone marrow biopsies performed for non-specific, diffuse marrow signal alterations on magnetic resonance imaging.
Jones TE; Wyse AJ; Gibson SE
Ann Diagn Pathol; 2019 Jun; 40():7-12. PubMed ID: 30825791
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric phenotype of rhabdomyosarcoma bone marrow metastatic cells and its implication in differential diagnosis with neuroblastoma.
Bozzi F; Collini P; Aiello A; Barzanò E; Gambirasio F; Podda M; Meazza C; Ferrari A; Luksch R
Anticancer Res; 2008; 28(3A):1565-9. PubMed ID: 18630512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
